Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Once-weekly 2.4mg semaglutide led to a 12.7 kg (~28 lb) weight loss over placebo in the pivotal Phase 3 trial (NCT03548935)
Its part of a class of drugs called glucagon-like peptide 1 (GLP-1) receptor agonists, which help people with Type 2 diabetes lower their blood sugar and reduce their risk for cardiovascular disease
The deals they offer always get me to try new treatments
Interactions Compounded semaglutide can interact with other medications, including insulin and insulin-releasing medications, which can result in low blood sugar
There continues to be a gap between the number of prescriptions dispensed for ADMs (68.99% of patients filled an ADM GLP-1 RA prescription within 60 days) compared with AOMs (48.69% of patients filled an AOM GLP-1 RA prescription within 60 days)
